Gugliucci A, Menini T, Stahl A J
Département d'Immunologie, Immunopharmacologie et Pathologie, Faculté de Pharmacie, Université Louis Pasteur, Illkirch, France.
Biochem Mol Biol Int. 1994 Jan;32(1):139-47.
We describe a simplified method for studying the susceptibility to in vitro autoxidation of lipoproteins containing apolipoprotein B. It comprises copper induced autoxidation of VLDL+LDL plasma fractions and an assay for thiobarbituric acid reactive soluble substances. We studied autoxidation of VLDL+LDL in a population of 30 healthy subjects and a population of 30 diabetic patients. No significant difference in susceptibility to autoxidation could be detected. Protection afforded by ascorbic acid amounted to more than 95% at concentrations easily attainable in vivo by oral supplementation. Thiobarbituric acid reactive substances were higher in plasma from diabetic patients: 0.51 +/- 0.25 mumol/l vs 0.35 +/- 0.07 mumol/l for control subjects (p < 0.001). Our data confirm the presence of higher levels of lipid peroxides in diabetic patients, but fail to demonstrate any difference in susceptibility to oxidation of apolipoprotein B containing particles between control and diabetic subjects.
我们描述了一种用于研究含载脂蛋白B的脂蛋白体外自氧化敏感性的简化方法。该方法包括铜诱导的极低密度脂蛋白(VLDL)+低密度脂蛋白(LDL)血浆组分的自氧化以及硫代巴比妥酸反应性可溶性物质的测定。我们研究了30名健康受试者和30名糖尿病患者群体中VLDL+LDL的自氧化情况。未检测到自氧化敏感性的显著差异。通过口服补充在体内易于达到的浓度下,抗坏血酸提供的保护作用超过95%。糖尿病患者血浆中的硫代巴比妥酸反应性物质含量较高:对照组受试者为0.35±0.07μmol/L,糖尿病患者为0.51±0.25μmol/L(p<0.001)。我们的数据证实糖尿病患者体内脂质过氧化物水平较高,但未能证明对照组和糖尿病患者之间含载脂蛋白B颗粒的氧化敏感性存在任何差异。